✨ Medicine Distribution Notices




20 OCTOBER 2005

NEW ZEALAND GAZETTE, No. 177

4499

Product:
Certican
Active Ingredient:
Everolimus 0.25mg
Dosage Form:
Dispersible tablet
New Zealand Sponsor:
Novartis New Zealand Limited Pharmaceutical Sector
Manufacturers:
Novartis Pharma AG, Basel, Switzerland
Novartis Pharma AG, Stein, Switzerland

Product:
Certican
Active Ingredient:
Everolimus 0.25mg
Dosage Form:
Tablet
New Zealand Sponsor:
Novartis New Zealand Limited Pharmaceutical Sector
Manufacturers:
Novartis Pharma AG, Basel, Switzerland
Novartis Pharma AG, Stein, Switzerland

Product:
Certican
Active Ingredient:
Everolimus 0.5mg
Dosage Form:
Tablet
New Zealand Sponsor:
Novartis New Zealand Limited Pharmaceutical Sector
Manufacturers:
Novartis Pharma AG, Basel, Switzerland
Novartis Pharma AG, Stein, Switzerland

Product:
Certican
Active Ingredient:
Everolimus 0.75mg
Dosage Form:
Tablet
New Zealand Sponsor:
Novartis New Zealand Limited Pharmaceutical Sector
Manufacturers:
Novartis Pharma AG, Basel, Switzerland
Novartis Pharma AG, Stein, Switzerland

Product:
Certican
Active Ingredient:
Everolimus 1mg
Dosage Form:
Tablet
New Zealand Sponsor:
Novartis New Zealand Limited Pharmaceutical Sector
Manufacturers:
Novartis Pharma AG, Basel, Switzerland
Novartis Pharma AG, Stein, Switzerland

Product:
Metamucil Lemon Lime Flavour Smooth Texture
Active Ingredient:
Ispaghula husk 541.38mg/g
Dosage Form:
Powder for oral solution
New Zealand Sponsor:
Procter & Gamble Distributing New Zealand
Manufacturer:
Procter & Gamble Pharmaceuticals, Phoenix, Arizona, United States of America

Product:
Metamucil Regular Flavour Smooth Texture
Active Ingredient:
Ispaghula husk 583.33mg/g
Dosage Form:
Powder for oral solution
New Zealand Sponsor:
Procter & Gamble Distributing New Zealand
Manufacturer:
Procter & Gamble Pharmaceuticals, Phoenix, Arizona, United States of America

Product:
Recormon 60,000 for Reco-Pen
Active Ingredient:
Epoetin beta 60,000IU equivalent to 498Β΅g
Dosage Form:
Front compartment Powder for injection
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany

Dated this 12th day of October 2005.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go6928

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product:
Velcade
Active Ingredient:
Bortezomib 3.5mg
Dosage Form:
Powder for injection
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Manufacturer:
Ben Venue Laboratories Inc, Bedford, Ohio, United States of America



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2005, No 177


Gazette.govt.nz PDF NZ Gazette 2005, No 177





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
12 October 2005
Medicines, Distribution, Certican, Everolimus, Metamucil, Recormon
  • DON MATHESON, Deputy Director-General, Public Health

πŸ₯ Provisional Consent to the Distribution of a New Medicine

πŸ₯ Health & Social Welfare
Medicines, Provisional Consent, Velcade, Bortezomib